Shares of Modern Diagnostic & Research Centre made a positive entry into the secondary market on Wednesday, January 7, 2026. The pathology and radiology services provider listed on the BSE SME platform at a premium to its issue price, reflecting healthy investor interest. The debut followed a strongly subscribed initial public offering that raised ₹36.89 crore.
Modern Diagnostic shares began trading at ₹99.50 per share on the BSE SME, marking a premium of ₹9.50, or 10.56%, over the IPO price of ₹90. The listing indicated a favourable reception from the market after the completion of the public issue.
The IPO consisted entirely of a fresh issue of 4.1 million equity shares, aggregating to ₹36.89 crore. There was no offer-for-sale component, meaning all proceeds are expected to be used for business-related purposes. The price band for the issue was fixed between ₹85 and ₹90 per share, with a minimum lot size of 1,600 shares.
The public issue witnessed strong demand across investor categories, with overall subscriptions reaching 350.49 times. Non-institutional investors led participation, subscribing their portion 519.38 times. Retail investors subscribed 342.46 times, while qualified institutional buyers recorded subscriptions of 193.51 times, as per BSE data.
The IPO was open for subscription from December 31, 2025, to January 2, 2026. The basis of allotment was finalised on January 5, 2026, and the issue price was set at ₹90 per share, the upper end of the announced price band.
Read More: Gold and Silver Prices Today, January 7, 2026: Check Rates in Chennai, Bangalore and Hyderabad.
Modern Diagnostic’s market debut reflects positive investor sentiment following robust IPO participation. The company’s prospects, future performance will depend on execution, financial performance, and broader market conditions.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jan 7, 2026, 12:11 PM IST
Neha Dubey
Neha Dubey is a Content Analyst with 3 years of experience in financial journalism, having written for a leading newswire agency and multiple newspapers. At Angel One, she creates daily content on finance and the economy. Neha holds a degree in Economics and a Master’s in Journalism.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
EN